Search for: "PFIZER" Results 3021 - 3040 of 4,635
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jul 2011, 11:39 am by Wystan M. Ackerman
Coordination of litigation and regulatory inquiries:  Amanda Perez, in-house counsel at Pfizer, talked about how she has addressed situations where Pfizer is faced with an issue that leads to a regulatory inquiry and multiple fronts of litigation at the same time. [read post]
23 Jun 2017, 3:56 am by NCC Staff
City planners sought to transfer land to the New London Development Corporation, a private nonprofit organization, which in turn would develop the land as a new facility for Pfizer. [read post]
19 May 2020, 10:37 am by Miquel Montañá (Clifford Chance)
Moving on to the national plane, the first judgment this author is aware of where a Spanish Court ordered a permanent injunction in a situation where no acts of infringement or even “imminent” infringement had been established is the judgment of 17 May 2006 (Warner-Lambert,  Geodecke and Pfizer v. [read post]
7 Jan 2008, 6:18 am
And Pfizer has now seen its trial loss erased by entry of judgment notwithstanding the verdict. [read post]
10 Jun 2010, 3:58 am
Cir. 2010) – Further adventures in obviousness and inequitable conduct (Patent Docs) Viagra (Sildenafil) – Australia: You had me at Viagra – Pfizer successfully opposes VIAGUARA for alcoholic beverages (IP Whiteboard) Yaz (Drospirenone & Ethinyl Estradiol) – US: Patent infringement complaint / application for declaratory judgment of noninfringment Bayer Schering et al. v. [read post]
25 Aug 2016, 1:52 pm by Ahmed Shehata
The Industrials & Chemicals sector lead the way with US$244bn in transaction value and 1486 deals, despite New Treasury rules aimed at dissuading tax inversions leading to the termination of the US$183.7bn Pfizer and Allergan transaction. [read post]
24 May 2024, 2:01 am by H. Juanita Beecher, FortneyScott
Pfizer, the appeals court said the identity of at least one of the students is necessary to determine whether the individuals “are not merely enabling the organization to lodge a hypothetical legal challenge. [read post]
6 Jul 2010, 6:03 pm by Duncan
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs)   Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market generic (Patent Docs)… [read post]
13 Apr 2012, 7:19 am by admin
In 2009, Pfizer settled for $2.3 billion over marketing of its painkiller Bextra. [read post]
9 May 2011, 11:38 am by Ted Allen
Pfizer and J&J both received more than 39 percent dissent, nearly four times the average opposition rate this year. [read post]
27 Aug 2009, 4:20 am
The court had originally denied Pfizer’s Daubert challenge to Dr. [read post]
5 Feb 2008, 7:19 am
In a statement, Pfizer said it hasn't identified any evidence an increased risk of suicide-related events in Lyrica or Neurontin based on a review of clinical studies and post-marketing reports. [read post]
8 Jul 2011, 7:05 am
Vitals: Research Review Links Pfizer's Chantix to Heart Problems, Katherine Hobson, 07.05.2011. [read post]
7 Jan 2008, 6:18 am
And Pfizer has now seen its trial loss erased by entry of judgment notwithstanding the verdict. [read post]
10 Apr 2017, 10:15 am by Vada W. Lindsey
Ironically, after the homes in the Fort Trumbull neighborhood were razed for the project, Pfizer never developed the property and it remains vacate today. [read post]
25 Jan 2011, 10:58 pm by Marie Louise
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
8 Dec 2016, 3:20 am by Brian Cordery
Kalden, Brinkman and Van Nispen10) How many defendants were there to the Danish action brought by Warner-Lambert and Pfizer in relation to Krka’s generic pregabalin in 2015? [read post]
22 Jan 2010, 12:03 am by Dr. Shezad Malik
., now owned by Pfizer] was entirely dismissive of any such connection ... it defies logic, contrary to the trial court's suggestion, that appellant [Simon] should have been aware of the risk of taking HRT through her own due diligence. [read post]
18 Oct 2011, 9:32 am
.; Ellen Rosenthal, vice president and assistant general counsel litigation/chief counsel at Pfizer Legal Alliance, Pfizer Inc.; and Erika Rottenberg, vice president, general counsel, and secretary for LinkedIn.Jelich will help provide practical guidance for in-house counsel and law firms seeking to bridge the gap between value and the cost of legal services.Currently based in London, England on assignment for RBC, Jelich says it’s an interesting time in the economic cycle in… [read post]